Dehainault C, Laugé A, Caux-Moncoutier V, Pagès-Berhouet S, Doz F, Desjardins L, Couturier J, Gauthier-Villars M, Stoppa-Lyonnet D, Houdayer C
Service de Génétique Oncologique, Pathologie Moléculaire des Cancers, Institut Curie, Paris, France.
Nucleic Acids Res. 2004 Oct 11;32(18):e139. doi: 10.1093/nar/gnh137.
Screening for large gene rearrangements is established as an important part of molecular medicine but is also challenging. A variety of robust methods can detect whole-gene deletions, but will fail to detect more subtle rearrangements that may involve a single exon. In this paper, we describe a new, versatile and robust method to assess exon copy number, called multiplex PCR/liquid chromatography assay (MP/LC). Multiple exons are amplified using unlabeled primers, then separated by ion-pair reversed-phase high-performance liquid chromatography (IP-RP-HPLC), and quantitated by fluorescent detection using a post-column intercalation dye. The relative peak intensities for each target directly reflect exon copy number. This novel technique was used to screen a panel of 121 unrelated retinoblastoma patients who were tested previously using a reference strategy. MP/LC correctly scored all deletions and demonstrated a previously undetected RB1 duplication, the first to be described. MP/LC appears to be an easy, versatile, and cost-effective method, which is particularly relevant to denaturing HPLC (DHPLC) users since it broadens the spectrum of available applications on a DHPLC system.
对大基因重排进行筛查已成为分子医学的重要组成部分,但也颇具挑战性。多种可靠方法能够检测全基因缺失,但对于可能涉及单个外显子的更为细微的重排则无法检测到。在本文中,我们描述了一种全新的、通用且可靠的评估外显子拷贝数的方法,称为多重PCR/液相色谱分析(MP/LC)。使用未标记引物扩增多个外显子,然后通过离子对反相高效液相色谱(IP-RP-HPLC)进行分离,并使用柱后插入染料通过荧光检测进行定量。每个靶标的相对峰强度直接反映外显子拷贝数。这项新技术被用于筛查一组121名无关的视网膜母细胞瘤患者,这些患者此前已采用参考策略进行检测。MP/LC正确识别了所有缺失情况,并发现了一个此前未检测到的RB1重复,这是首次被描述的此类情况。MP/LC似乎是一种简便、通用且经济高效的方法,对于变性高效液相色谱(DHPLC)用户而言尤为适用,因为它拓宽了DHPLC系统可用应用的范围。